AJP - Heart Information on EB 2010
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Heart Circ Physiol 287: H595-H600, 2004. First published April 1, 2004; doi:10.1152/ajpheart.00184.2004
0363-6135/04 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
287/2/H595    most recent
00184.2004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (37)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bátkai, S.
Right arrow Articles by Kunos, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bátkai, S.
Right arrow Articles by Kunos, G.

Cannabinoid antagonist SR-141716 inhibits endotoxic hypotension by a cardiac mechanism not involving CB1 or CB2 receptors

Sándor Bátkai,* Pál Pacher,* Zoltán Járai, Jens A. Wagner, and George Kunos

Laboratory of Physiologic Studies, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland 20892

Submitted 26 February 2004 ; accepted in final form 18 March 2004

Endocannabinoids and CB1 receptors have been implicated in endotoxin (LPS)-induced hypotension: LPS stimulates the synthesis of anandamide in macrophages, and the CB1 antagonist SR-141716 inhibits the hypotension induced by treatment of rats with LPS or LPS-treated macrophages. Recent evidence indicates the existence of cannabinoid receptors distinct from CB1 or CB2 that are inhibited by SR-141716 but not by other CB1 antagonists such as AM251. In pentobarbital-anesthetized rats, intravenous injection of 10 mg/kg LPS elicited hypotension associated with profound decreases in cardiac contractility, moderate tachycardia, and an increase in lower body vascular resistance. Pretreatment with 3 mg/kg SR-141716 prevented the hypotension and decrease in cardiac contractility, slightly attenuated the increase in peripheral resistance, and had no effect on the tachycardia caused by LPS, whereas pretreatment with 3 mg/kg AM251 did not affect any of these responses. SR-141716 also elicited an acute reversal of the hypotension and decreased contractility when administered after the response to LPS had fully developed. The LPS-induced hypotension and its inhibition by SR-141716 were similar in pentobarbital-anesthetized wild-type, CB1–/–, and CB1–/–/CB2–/– mice. We conclude that SR-141716 inhibits the acute hemodynamic effects of LPS by interacting with a cardiac receptor distinct from CB1 or CB2 that mediates negative inotropy and may be activated by anandamide or a related endocannabinoid released during endotoxemia.

endotoxin; cannabinoids; negative inotropy


Address for reprint requests and other correspondence: G. Kunos, NIAAA, 12420 Parklawn Dr., MSC-8115, Bethesda, MD 20892-8115 (E-mail gkunos{at}mail.nih.gov).




This article has been cited by other articles:


Home page
 J. Leukoc. Biol.Home page
A. E. B. Springs, P. W. F. Karmaus, R. B. Crawford, B. L. F. Kaplan, and N. E. Kaminski
Effects of targeted deletion of cannabinoid receptors CB1 and CB2 on immune competence and sensitivity to immune modulation by {Delta}9-tetrahydrocannabinol
J. Leukoc. Biol., December 1, 2008; 84(6): 1574 - 1584.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
Y. Wang, M. Novotny, V. Quaiserova-Mocko, G. M. Swain, and D. H. Wang
TRPV1-mediated protection against endotoxin-induced hypotension and mortality in rats
Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2008; 294(5): R1517 - R1523.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
S. Batkai, D. Osei-Hyiaman, H. Pan, O. El-Assal, M. Rajesh, P. Mukhopadhyay, F. Hong, J. Harvey-White, A. Jafri, G. Hasko, et al.
Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury
FASEB J, June 1, 2007; 21(8): 1788 - 1800.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
A. Bilkei-Gorzo, I. Racz, O. Valverde, M. Otto, K. Michel, M. Sastre, and A. Zimmer
Early age-related cognitive impairment in mice lacking cannabinoid CB1 receptors
PNAS, October 25, 2005; 102(43): 15670 - 15675.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
P. Pacher, S. Batkai, D. Osei-Hyiaman, L. Offertaler, J. Liu, J. Harvey-White, A. Brassai, Z. Jarai, B. F. Cravatt, and G. Kunos
Hemodynamic profile, responsiveness to anandamide, and baroreflex sensitivity of mice lacking fatty acid amide hydrolase
Am J Physiol Heart Circ Physiol, August 1, 2005; 289(2): H533 - H541.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
S. M. Gardiner, J. E. March, P. A. Kemp, and T. Bennett
Involvement of CB1-receptors and {beta}-adrenoceptors in the regional hemodynamic responses to lipopolysaccharide infusion in conscious rats
Am J Physiol Heart Circ Physiol, May 1, 2005; 288(5): H2280 - H2288.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
S. M. Gardiner, T. Bennett, G. Kunos, S. Batkai, P. Pacher, J. A. Wagner, and Z. Jarai
Cannabinoids and Endotoxemia
Am J Physiol Heart Circ Physiol, January 1, 2005; 288(1): H451 - H451.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2004 by the American Physiological Society.